Perceptive Advisors LLC holds 7.6% of Immatics N.V., or 11,418,016 ordinary shares, after the Master Fund bought 863,060 shares at $8.69 each. The 13D classification marks the position as activist rather than passive, while the ownership calculation assumes vested Options tied to Adam Stone’s board service.

Key Highlights

  • Perceptive Life Sciences Master Fund purchased 863,060 Immatics ordinary shares at $8.69 per share on August 26, 2026.
  • The 7.6% ownership calculation uses 149,635,893 ordinary shares outstanding.
  • Adam Stone holds options for 219,500 ordinary shares, including 171,500 exercisable or available within 60 days.

Perceptive Advisors LLC holds 7.6% of Immatics N.V., equal to 11,418,016 ordinary shares. The position is covered by a Schedule 13D amendment identified as an activist filing. Perceptive Life Sciences Master Fund Ltd. and Joseph Edelman are also listed among the reporting persons.

Position Includes Options

The ownership percentage is calculated against 149,635,893 Immatics ordinary shares outstanding.

Stone, Perceptive Advisors’ chief Investment officer, holds options covering 219,500 ordinary shares. Of that total, 171,500 are currently exercisable or can be exercised within 60 days.

The securities are ordinary shares with a nominal value of EUR 0.01 per share.

August 26 Share Purchase

Perceptive Life Sciences Master Fund bought 863,060 Immatics ordinary shares on August 26, 2026, at $8.69 per share. The purchase took place in Immatics’ underwritten offering and was funded with the Master Fund’s working capital.

Perceptive Advisors LLC, the Master Fund and Edelman each signed the documents on August 27, 2026.

Peers Moving on This News

Source(s)

  • https://www.sec.gov/Archives/edgar/data/1809196/000119312526371236/primary_doc.xml